<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">REASON FOR VISIT</a></li><li><a href="#id2">PROBLEMS</a></li><li><a href="#id3">Encounters</a></li><li><a href="#id4">ASSESSMENTS</a></li><li><a href="#id5">PLAN OF TREATMENT</a></li><li><a href="#id6">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">REASON FOR VISIT</a></h3><div>Tele visit</div><h3><a name="id2" href="#toc">PROBLEMS</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>SNOMED Code</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td ID="Problem1">Malignant neoplasm of prostate (C61)</td><td/><td>Active</td><td>confirmed</td><td/><td>399068003</td><td/></tr><tr><td>Problem</td><td ID="Problem2">Immunodeficiency due to conditions classified elsewhere (D84.81)</td><td/><td>Active</td><td>confirmed</td><td/><td>33286000</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Medical Associates Of Tamarac Pa</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Malignant neoplasm of prostate C61 and Immunodeficiency due to conditions classified elsewhere D84.81</td></tr></tbody></table></div><h3><a name="id4" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td>controled on Xtandi</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td/><td>due to Xtandi and controlled on mask wearing</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Malignant neoplasm of prostate</td><td>controled on Xtandi</td></tr><tr><td ID="instructionpot2">Immunodeficiency due to conditions classified elsewhere</td><td>due to Xtandi and controlled on mask wearing</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED] H [REDACTED], [REDACTED] 08:45:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 60421 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED] A<br/><span class="bold">Account Number: </span>60421</td><td align="right"/></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>66 Y<span class="bold">   Sex: </span>Male</td><td align="right"/></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Tele visit</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">general</span>: <br/>       Patients Location HOME. Providers Location OFFICE.<br/>           Consent This visit was conducted with the use of audio-visual telecommunications system that permits real-time communication between the patient and the provider. I introduced myself to the patient, and the patient confirmed his/her identity and location. I determined that, in my professional judgment, there was no impediment on the patient's ability to communicate effectively with me and that we could proceed. The patient's consent for this telehealth visit was obtained and during which I explained there are inherent limits to telemedicine services including: potential technology failures that could interrupt service or treatment; that telehealth should not be used for emergency medical conditions; and potential risks associated with the privacy and security of the technology. I assessed and managed the patient as below. <br/>           telehealth visit for prostate cancer and being treated with Xtandi with [REDACTED].</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Malignant neoplasm of prostate - C61 (Primary) 2. Immunodeficiency due to conditions classified elsewhere - D84.81 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Malignant neoplasm of prostate</span> <br/>Notes: controled on Xtandi  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Immunodeficiency due to conditions classified elsewhere</span> <br/>Notes: due to Xtandi and controlled on mask wearing  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 99442 PHONE E/M BY PHYS 11-20 MIN</td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"/><td align="right"><span class="bold">Date: </span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/>
</body></html>